Telomerase reverse transcriptase mutation: A risk predictor and drug target for oral squamous cell carcinoma and its precursors

Oral Oncol. 2022 Nov:134:106120. doi: 10.1016/j.oraloncology.2022.106120. Epub 2022 Sep 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma, Squamous Cell* / genetics
  • Carcinoma, Squamous Cell* / pathology
  • Head and Neck Neoplasms*
  • Humans
  • Mouth Neoplasms* / genetics
  • Mouth Neoplasms* / pathology
  • Mutation
  • Squamous Cell Carcinoma of Head and Neck
  • Telomerase* / genetics
  • Telomerase* / metabolism

Substances

  • Telomerase